Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

NCT00807612 is registered in ClinicalTrials.gov with NantCell, Inc. as lead sponsor.

NCT NCT00807612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00807612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Lead sponsor
NantCell, Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2009
Completion date
August 31, 2010
Enrollment
15 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

advanced squamous non-small cell lung cancer